Following #ihmc2022 online this week, I have a poster on my recent paper ( https://t.co/mmbP9btZEk) that can be viewed via the online portal, happy to answer any questions!

Was a great pleasure to present our recent publication about the genome-to-microbiome association ( https://t.co/LW1zUVt09r) and a poster of an ongoing project about the longitudinal gut microbiome at #iccmg @IccMg. Thank you to @tisonjl for the photo of me on stage!

Yesterday the ESRs Sara Leal and Emmanouil Nychas presented their work at the #ICSB2022

Great BestTreat article entitled "Can microbiota modulation prevent the development of fatty liver disease?" appearing in Project Repository Journal

I was happy to present at #NAFLDsummit @EASLedu what I have been busy with in @amsterdamumc

The findings of a new research reveal the microbiota alterations during NAFLD and suggest that gut microbes can be used as an early clinical sign of the condition.

A large prospective study sheds light on the connection between the gut #microbiome and early #NAFLD development in patients – offering potential microbial markers for future efforts to predict and diagnose cases. @LeibnizHKI @BestTreat #MachineLearning https://t.co/dswJdbaIiD

Amazing work from @BestTreat. Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine and stool  https://t.co/UXRHo4YoG2  (@SciReports)

Chronic liver disease can be predicted by looking at the gut microbiome: A group of international researchers led by Gianni Panagiotou developed a machine-learning model for risk assessment. 🖥️🧬@microverse_exc @MSCActions @dfg_public @BestTreat https://t.co/R4HMIkldyh

BestTreat new publication "Risk assessment with gut microbiome and metabolite markers in NAFLD development" appearing in Science Translational Medicine.

Thank you so much 👏 to all of the FHMSI attendees and speakers for the excellent feedback📝

Karl Alex Hedin, BestTreat ESR and winner of the Best Poster Presentation at the Frontiers in Host-Microbiota Symbiotic Interactions Symposium, is congratulated.

LC–MS/MS as a valuable tool for screening metabolites! Learn more about How the Identification and Distribution of Sterols, Bile Acids, and Acylcarnitines by LC–MS/MS in different samples was facilitated; in the new BestTreat publication

How physical activity and dietary intake were associated with gut microbiota composition in a multi-ethnic cohort? You can learn more about this in the newly released BestTreat publication https://t.co/AVjbVIe0ce

How the food you eat affects your gut https://t.co/ayLOpJAMGe

The abstract submission deadline for the "Frontiers in Host-Microbiota symbiotic Interaction symposium Berlin, Feb 9-11, 2022" has been extended to 31st of October 2021. Looking forward to your contribution on https://t.co/gM6ucTvHZb

Join our Symposium “FRONTIERS IN HOST-MICROBIOTA SYMBIOTIC INTERACTIONS"  9-11 February, 2022 in Berlin More information about the program and symposium: https://t.co/prUWxnVj94 https://t.co/1JDklwNz28

BestTreat new publication "Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis " appearing in Nutrients. Read the full article here

BestTreat symposium: Now the registration and abstract submission are open Looking forward to your contribution https://t.co/TvrVKfkuGY

We just accomplished with success our 7th biannual meeting. An impressive progress in the research work of our ESRs and a prolific discussion with PIs and supervisory board members.